Singapore
WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...
September 22, 2026 | News
Accro Bioscience Inc. (Accro Bio), a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated diseases, an...
September 22, 2026 | News
Specialised Therapeutics announced an expansion of its existing partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ: IN...
September 22, 2026 | News
Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, with DKSH's launch of Colpofix&...
September 22, 2026 | News
Gladys Wang, Vice President, Bioprocessing, Asia Pacific, Avantor, says: “Customers across APAC are looking for reliable single-use solutions that ca...
September 18, 2026 | News
Novo Holdings, a leading global healthcare and life sciences investor, announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd...
September 14, 2026 | News
HIMSS26 APAC a flagship digital health event for the Asia-Pacific region at Marina Bay Sands Expo and Convention Centre in Singapore. During the event, Hua...
September 09, 2026 | News
Collaboration will explore clinical education, knowledge exchange and imaging excellence across Southeast Asia Tucker Medical has installed a SIGNA&trad...
September 07, 2026 | News
Healthcare packaging plays a critical role in protecting product integrity, supporting sterilization requirements, and helping medical products reach healt...
September 01, 2026 | News
"From September 2026 – eligible patients receiving vutrisiran will receive government subsidies of up to 75%[1],[2]" "HELIOS-A and B provide strong ...
September 02, 2026 | News
WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organizati...
September 01, 2026 | News
Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue GenScript Biotech Corporation (HKEX: 154...
August 20, 2026 | Company results
Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 Blenrep, a f...
August 20, 2026 | News
WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on t...
August 19, 2026 | News
Most Read
Bio Jobs
News